EUR 19.0
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -39.89 Thousand EUR | 87.44% |
2022 | -317.51 Thousand EUR | 0.0% |
2020 | -48.88 Thousand EUR | -121.63% |
2019 | 226 Thousand EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2021 Q1 | 789.43 Thousand EUR | 0.0% |
2020 FY | -48.88 Thousand EUR | -121.63% |
2019 FY | 226 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Crossject Société Anonyme | -11.8 Million EUR | 99.662% |
Safe Orthopaedics SA | -5.96 Million EUR | 99.331% |
Spineway SA | -9.03 Million EUR | 99.558% |
Amplitude Surgical SA | 13.24 Million EUR | 100.301% |
Sartorius Stedim Biotech S.A. | 484.5 Million EUR | 100.008% |
EssilorLuxottica Société anonyme | 3.17 Billion EUR | 100.001% |